Breast Biopsy Devices Market

Breast Biopsy Devices Market by Type (Needles, Tables, Assay kits, Liquid Biopsy), Procedure (CNB, FNAB, VAB, Surgical), Technique (Stereotactic, USG, MRI), Application (Screening, Treatment), End User (Hospitals, Clinic) & Region - Global Forecast to 2028

Report Code: MD 3615 Aug, 2023, by marketsandmarkets.com

The global breast biopsy devices market in terms of revenue was estimated to be worth $1.6 billion in 2023 and is poised to reach $2.6 billion by 2028, growing at a CAGR of 10.0% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The increasing incidence of breast cancer, growing breast cancer screening programs initiatives by the government, raising consciousness regarding early detection of breast cancer, and availability of reimbursements to drive the market during the forecast period.

Global Breast Biopsy Devices Market

Breast Biopsy Market

To know about the assumptions considered for the study, Request for Free Sample Report

Breast Biopsy Market

e- Estimated; p- Projected

Breast Biopsy Market Dynamics

Driver: Increasing number of breast cancer screening programs

Globally, the most frequently occurring cancer among women; it affects around 2.26 million women across the globe. In 2020, an estimated 685,000 deaths were caused owing to breast cancer, accounting for 15% of cancer-related deaths among women. A key contributor to the high death rate is that most women are diagnosed with late-stage cancer.

  • The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) was initiated by the Centers for Disease Control and Prevention (CDC) in 1991 for early breast and cervical cancer detection in the US. This program aims to provide annual breast cancer screening and diagnosis for uninsured and low-income women in the country. In 2021, NBCCEDP provided breast cancer screening and diagnostic services to 263,651 women and diagnosed 2,221 invasive breast cancers and 676 premalignant breast lesions.
  • The rising number of such initiatives in major global markets is expected to increase the number of screening procedures for breast cancer diagnosis. This, in turn, is expected to drive the growth of the breast biopsy market.

Restraint: Risk of infections associated with the use of biopsy needles

The size and quality of biopsy samples can vary, which can be challenging to obtain enough tissue for an accurate diagnosis. Patients may experience anxiety and fear regarding biopsy procedures due to concerns about pain, complications, or receiving a cancer diagnosis. This can lead to delayed diagnosis and treatment. Although healthcare authorities and manufacturers advise against needle reuse, the practice is still prevalent in developing countries.

Opportunity: Emergence of liquid biopsy and promising clinical trials

Over time, biopsy techniques have undergone significant advancements, transitioning from open surgical procedures to minimally invasive needle biopsies. These advancements have been driven by the increasing demand for less invasive biopsy techniques from surgeons and patients.

Liquid biopsy detected circulating tumor cells or DNA fragments from tumors and emerged as a breakthrough technique. It eliminates the need for surgical or needle biopsies and enables early-stage cancer detection. This approach captures the comprehensive genetic complexity of tumors and reduces the risk of cancer cells spreading to other parts of the body. Multiple players in the market are currently conducting clinical trials to validate the effectiveness and efficiency of liquid biopsy in oncology. Encouraging results from these trials is expected to create new opportunities for companies operating in the market.

Challenge: Underdeveloped Healthcare Infrastructure and Dearth of Resources in Developing Countries

The rising awareness of cancer types drives increased demand for biopsy procedures. However, a significant challenge is the need for more skilled surgeons who can perform minimally invasive biopsies. This shortage is particularly pronounced in developing and underdeveloped regions. For instance, the US is projected to face a shortage of over 2,300 medical oncologists by 2025, while growing areas like sub-Saharan Africa need more medical oncologists, radiation oncologists, and other essential healthcare professionals. These shortages of healthcare professionals hinder the adoption of breast biopsy needle procedures, particularly in developing countries.

Furthermore, the underdeveloped healthcare infrastructure in many regions significantly constrains the growth of the breast biopsy market. In countries like India, low screening coverage for breast and cervical cancer is attributed to inadequate laboratory supplies, limited treatment accessibility, and cultural and religious beliefs impacting diagnosis.

Breast Biopsy Devices Market Ecosystem

Breast Biopsy Market Ecosystem

By type, the biopsy needles segment accounted for the largest share of the breast biopsy devices industry in 2022.

Based on type, the global breast biopsy devices market is segmented into biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments, and other devices. In 2023, the biopsy needles segment accounted for the largest market share. Technological advancements and new product launches drive the growth potential of the biopsy needles segment. Moreover, government initiatives supporting breast cancer screening programs and awareness campaigns are expected to increase the adoption of breast biopsy procedures, further fueling market growth.

By procedure, the liquid breast biopsy segment of the breast biopsy devices industry will register significant growth soon.

Based on procedure, the global near breast biopsy devices market is segmented into needle breast biopsy, open surgical breast biopsy, and liquid breast biopsy. In 2023, the liquid breast biopsy segment registered the highest growth rate during the forecast period. Companies in the liquid breast biopsy segment are actively providing financial support and grants for clinical trials and research. This proactive approach is expected to contribute significantly to the growth of the liquid breast biopsy market.

By technique, the image-guided biopsy segment of the breast biopsy devices industry will register significant growth soon.

Based on technique, the global breast biopsy market is segmented into liquid breast biopsy, image-guided biopsy, and liquid biopsy. The liquid biopsy segment registers the highest growth rate during the forecast period. The growth of this segment can be attributed to the enhanced accuracy provided by image-guided procedures in localizing abnormal or irregular masses, surpassing the accuracy achieved by non-image-guided procedures. This improved accuracy contributes to the segment’s expansion and presents advantageous opportunities in the business realm.

By application, the early cancer screening segment of the breast biopsy devices industry will register significant growth soon.

Based on application, the global breast biopsy devices market is segmented into early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring. Therapy selection registers the highest growth rate during the forecast period. Using liquid biopsy procedures has facilitated early-stage cancer diagnosis, real-time disease progression assessment, and recurrence monitoring. This advancement is anticipated to be a significant driver of market growth in the near future, presenting promising opportunities for businesses operating in the industry.

By end user, the hospitals and surgical centers companies segment accounted for the largest share of the breast biopsy devices industry in 2022.

Based on end-user, the global breast biopsy devices market is segmented into hospitals & clinics, research laboratories, and pharmaceutical & biotechnology companies. In 2023, hospitals and clinics accounted for the largest market share. The substantial market share of this segment can be primarily attributed to the rising volume of breast diagnostic procedures conducted in hospitals. This growth is driven by hospitals increasing preference for the automation and digitization of radiology patient workflow, as well as their adoption of technologically advanced systems to enhance the quality of patient care. These factors contribute significantly to the segment’s strong position in the market, presenting favorable opportunities for business growth in the healthcare industry.

By region, North America is expected to be the largest region of the breast biopsy devices industry during the forecast period.

North America, comprising the US and Canada, accounted for the largest share of the breast biopsy devices industry in 2022. The significant market share of the North American region can be attributed to several critical factors, including continuous technological advancements, increasing incidence rates of breast cancer, favorable reimbursement scenarios, and the implementation of new breast density notification laws in the US. These factors have played a pivotal role in driving the dominant position of the North American market, creating favorable business opportunities for companies operating in the region.

Breast Biopsy Market by Region

To know about the assumptions considered for the study, download the pdf brochure

As of 2022, prominent players in the market are Hologic Inc. (US), Danaher Corporation (US), Becton Dickinson and Company (US), Argon Medical Devices (US), Merit Medical Systems (US), Menarini-Silicon Biosystems (Italy), Guardant Health, Inc. (US), NeoGenomics (US), Sysmex Inostics (Germany), Sterylab S.R.L. ( Italy), Biocept, Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Qiagen (Germany), Exact Sciences Corporation (US).

Scope of the Breast Biopsy Devices Industry:

Report Metric 

Details 

Market Revenue in 2023

$1.6 billion

Projected Revenue by 2028

$2.6 billion

Revenue Rate

Poised to Grow at a CAGR of 10.0%

Market Driver

Increasing number of breast cancer screening programs

Market Opportunity

Emergence of liquid biopsy and promising clinical trials

This report has segmented the global breast biopsy devices market to forecast revenue and analyze trends in each of the following submarkets:

By Type

  • Biopsy Needles
  • Guidance Systems
  • Biopsy Tables
  • Localization Wires
  • Assay Kits
  • Liquid Biopsy Instruments
  • Others

By Procedure

  • Needle Breast Biopsy
    • Core-Needle Biopsy (CNB)
    • Fine-Needle Aspiration Biopsy (FNAB)
    • Vacuum-Assisted Biopsy (VAB)
  • Open Surgical Breast Biopsy
    • Excisional
    • Incisional
  • Liquid Breast Biopsy
    • Circulating Tumor Cells
    • Circulating Tumor DNA (CtDNA)
    • Other Biomarkers

By Technique

  • Image Guided Biopsy
    • Mammo-Guided Stereotactic
    • Ultrasound-Guided
    • MRI-Guided
    • Other Image-Guided Techniques
  • Liquid Biopsy
    • NGS based Biopsy
    • PCR based Biopsy
    • Microarray-based Biopsy

By Application

  • Early Cancer Screening
  • Therapy Selection
  • Treatment Monitoring
  • Recurrence Monitoring
  • Global Breast Biopsy Devices Market, by End User
  • Hospitals & Surgical Centers
  • Breast Care Centers
  • Imaging & Diagnostic Centers

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa

Recent Developments of Breast Biopsy Devices Industry

  • Hologic, Inc, an innovative medical technology company primarily focused on improving women’s health, announced today that it has completed the purchase of SOMATEX Medical Technologies GmbH; the deal size is $64 million.
  • In 2022 Danaher Corporation launched Mammotome Revolve EX Dual Vacuum-Assisted Breast Biopsy System, the first vacuum-assisted biopsy device designed specifically for the excision of benign breast lesions and is twice as fast as traditional vacuum-assisted breast biopsy systems.
  • Argon Medical Devices announced the launch of the SuperCore advantage semi-automatic biopsy instrument’s newest addition to its soft tissue biopsy product portfolio in the united states. The next-generation soft tissue biopsy instrument provides a superior volume of tissue samples. Collecting more tissue volume may increase the likelihood of an accurate diagnosis.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 33)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED
           1.3.3 CURRENCY CONSIDERED
    1.4 STAKEHOLDERS 
    1.5 SUMMARY OF CHANGES 
           1.5.1 RECESSION IMPACT
 
2 RESEARCH METHODOLOGY (Page No. - 39)
    2.1 RESEARCH DATA 
          FIGURE 1 GLOBAL BREAST BIOPSY DEVICES MARKET: RESEARCH METHODOLOGY STEPS
          FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 3 BREAST BIOPSY DEVICES MARKET: BREAKDOWN OF PRIMARIES
                    2.1.2.1 Key data from primary sources
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
           2.2.1 VENDOR REVENUE-BASED MARKET ESTIMATION
                    FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
           2.2.2 END-USER-BASED MARKET SIZE ESTIMATION
                    FIGURE 6 BREAST BIOPSY DEVICES MARKET: END-USER-BASED ESTIMATION
           2.2.3 PRIMARY RESEARCH VALIDATION
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 7 DATA TRIANGULATION METHODOLOGY
    2.4 RESEARCH LIMITATIONS 
    2.5 RISK ASSESSMENT 
          TABLE 1 BREAST BIOPSY DEVICES MARKET: RISK ASSESSMENT ANALYSIS
    2.6 BREAST BIOPSY DEVICES MARKET: RECESSION IMPACT ANALYSIS 
 
3 EXECUTIVE SUMMARY (Page No. - 50)
    FIGURE 8 BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 9 BREAST BIOPSY DEVICES MARKET SHARE, BY PROCEDURE, 2023 VS. 2028
    FIGURE 10 BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION)
    FIGURE 11 BREAST BIOPSY DEVICES MARKET SHARE, BY APPLICATION, 2023 VS. 2028
    FIGURE 12 BREAST BIOPSY DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    FIGURE 13 GEOGRAPHICAL SNAPSHOT OF BREAST BIOPSY DEVICES MARKET
 
4 PREMIUM INSIGHTS (Page No. - 55)
    4.1 BREAST BIOPSY DEVICES MARKET OVERVIEW 
          FIGURE 14 INCREASING PREVALENCE OF BREAST CANCER TO DRIVE MARKET GROWTH
    4.2 BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 
          FIGURE 15 ASSAY KITS TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
    4.3 BREAST BIOPSY DEVICES MARKET, PROCEDURE, 2023 VS. 2028 (USD MILLION) 
          FIGURE 16 NEEDLE BREAST BIOPSY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
    4.4 BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION) 
          FIGURE 17 IMAGE-GUIDED BIOPSY TO ACCOUNT FOR LARGEST SHARE OF BREAST BIOPSY DEVICES MARKET IN 2028
    4.5 BREAST BIOPSY DEVICES MARKET, APPLICATION, 2023 VS. 2028 (USD MILLION) 
          FIGURE 18 EARLY CANCER SCREENING SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
    4.6 BREAST BIOPSY DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 
          FIGURE 19 BREAST CARE CENTERS TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
    4.7 BREAST BIOPSY DEVICES MARKET, BY REGION, 2021–2028 
          FIGURE 20 ASIA PACIFIC TO WITNESS HIGHEST GROWTH IN MARKET DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 61)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 21 BREAST BIOPSY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Growing incidence of breast cancer
                                FIGURE 22 NUMBER OF BREAST CANCER CASES, BY COUNTRY, 2020
                    5.2.1.2 Increasing number of breast cancer screening programs
                    5.2.1.3 Increasing demand for minimally invasive and non-invasive procedures
                    5.2.1.4 Growing awareness of early detection of breast cancer
                    5.2.1.5 Improved reimbursement scenario
                                TABLE 2 MEDICARE REIMBURSEMENT FOR BREAST BIOPSY PROCEDURES
           5.2.2 RESTRAINTS
                    5.2.2.1 Risk of infections associated with biopsy needles
                    5.2.2.2 Stringent regulatory approval procedures
                    5.2.2.3 Product recalls
                                TABLE 3 FDA-INITIATED PRODUCT RECALLS
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growth potential in emerging economies
                    5.2.3.2 Emergence of liquid biopsy and promising clinical trials
                                TABLE 4 LIQUID BIOPSY CLINICAL TRIALS
                    5.2.3.3 Increasing public-private investments and funding
           5.2.4 CHALLENGES
                    5.2.4.1 Shortage of skilled professionals and inadequate healthcare infrastructure
    5.3 REGULATORY LANDSCAPE 
           5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 9 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           5.3.2 REGULATORY ANALYSIS
                    5.3.2.1 North America
                               5.3.2.1.1 US
                                               TABLE 10 US FDA-APPROVED BIOPSY DEVICES
                                               TABLE 11 US FDA: MEDICAL DEVICE CLASSIFICATION
                                               TABLE 12 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                               5.3.2.1.2 Canada
                                               TABLE 13 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                    5.3.2.2 Europe
                    5.3.2.3 Asia Pacific
                               5.3.2.3.1 Japan
                                               TABLE 14 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
                               5.3.2.3.2 China
                                               TABLE 15 CHINA: CLASSIFICATION OF MEDICAL DEVICES
                               5.3.2.3.3 India
    5.4 VALUE CHAIN ANALYSIS 
           5.4.1 RESEARCH & DEVELOPMENT
           5.4.2 PROCUREMENT & PRODUCT DEVELOPMENT
           5.4.3 MARKETING, SALES & DISTRIBUTION, AND POST-SALES SERVICES
                    FIGURE 23 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
    5.5 SUPPLY CHAIN ANALYSIS 
           5.5.1 PROMINENT COMPANIES
           5.5.2 SMALL & MEDIUM-SIZED ENTERPRISES
           5.5.3 END USERS
                    FIGURE 24 BREAST BIOPSY DEVICES MARKET: SUPPLY CHAIN ANALYSIS
    5.6 ECOSYSTEM MARKET MAP 
          TABLE 16 BREAST BIOPSY DEVICES MARKET: ROLE IN ECOSYSTEM
    5.7 TECHNOLOGY ANALYSIS 
    5.8 TRADE ANALYSIS 
          TABLE 17 IMPORT DATA FOR BIOPSY NEEDLES (HS CODE 90183240), BY COUNTRY, 2018–2022 (USD THOUSAND)
          TABLE 18 EXPORT DATA FOR BREAST BIOPSY DEVICES (HS CODE 90183240), BY COUNTRY, 2018–2022 (USD THOUSAND)
          TABLE 19 IMPORT DATA FOR MAMMOGRAPHY DEVICES (HS CODE 90221411), BY COUNTRY, 2018–2022 (USD THOUSAND)
          TABLE 20 EXPORT DATA FOR MAMMOGRAPHY DEVICES (HS CODE 90221411), BY COUNTRY, 2018–2022 (USD THOUSAND)
    5.9 PATENT ANALYSIS 
          FIGURE 25 PATENT DETAILS FOR BREAST BIOPSY (JANUARY 2012–JULY 2023)
    5.10 PORTER’S FIVE FORCES ANALYSIS 
           TABLE 21 BREAST BIOPSY DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.10.1 THREAT OF NEW ENTRANTS
           5.10.2 THREAT OF SUBSTITUTES
           5.10.3 BARGAINING POWER OF SUPPLIERS
           5.10.4 BARGAINING POWER OF BUYERS
           5.10.5 INTENSITY OF COMPETITIVE RIVALRY
    5.11 PRICING ANALYSIS 
           5.11.1 AVERAGE SELLING PRICE OF PRODUCTS, BY TYPE
                     TABLE 22 AVERAGE SELLING PRICE OF PRODUCTS (USD), 2022
           5.11.2 AVERAGE SELLING PRICE TRENDS
    5.12 CASE STUDY ANALYSIS 
           5.12.1 CASE STUDY 1: EVOLUTION OF WIRE LOCALIZATION TECHNIQUE
                     FIGURE 26 BREAST TUMOR LOCALIZATION: TECHNOLOGY EVOLUTION CHART
           5.12.2 CASE STUDY 2: GROWING BREAST CARE FACILITIES IN US
    5.13 KEY CONFERENCES & EVENTS, 2023–2025 
           TABLE 23 BREAST BIOPSY DEVICES MARKET: LIST OF MAJOR CONFERENCES & EVENTS (2023–2025)
    5.14 KEY STAKEHOLDERS & BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS & BUYING CRITERIA
                     FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BREAST BIOPSY DEVICES
           5.14.2 BUYING CRITERIA
                     TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BREAST BIOPSY DEVICES
                     FIGURE 28 KEY BUYING CRITERIA FOR BREAST BIOPSY DEVICES
                     TABLE 25 KEY BUYING CRITERIA FOR BREAST BIOPSY DEVICES
 
6 BREAST BIOPSY DEVICES MARKET, BY TYPE (Page No. - 94)
    6.1 INTRODUCTION 
          TABLE 26 BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 27 BREAST BIOPSY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
    6.2 BIOPSY NEEDLES 
           6.2.1 TECHNOLOGICAL ADVANCEMENTS IN BIOPSY NEEDLES TO DRIVE MARKET GROWTH
                    TABLE 28 BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 29 BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 30 BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY TECHNIQUE, 2021–2028 (USD MILLION)
                    TABLE 31 BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 32 BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY END USER, 2021–2028 (USD MILLION)
    6.3 GUIDANCE SYSTEMS 
           6.3.1 PROCEDURAL ADVANTAGES OF GUIDED BIOPSIES TO FUEL GROWTH
                    TABLE 33 BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 34 BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 35 BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TECHNIQUE, 2021–2028 (USD MILLION)
                    TABLE 36 BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 37 BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY END USER, 2021–2028 (USD MILLION)
    6.4 BIOPSY                     TABLES 
           6.4.1 GROWING USE OF BIOPSY                     TABLES TO PERFORM STEREOTACTIC BIOPSY PROCEDURES TO FAVOR MARKET GROWTH
                    TABLE 38 BREAST BIOPSY DEVICES MARKET FOR BIOPSY TABLES, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 39 BREAST BIOPSY DEVICES MARKET FOR BIOPSY TABLES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 40 BREAST BIOPSY DEVICES MARKET FOR BIOPSY TABLES, BY TECHNIQUE, 2021–2028 (USD MILLION)
                    TABLE 41 BREAST BIOPSY DEVICES MARKET FOR BIOPSY TABLES, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 42 BREAST BIOPSY DEVICES MARKET FOR BIOPSY TABLES, BY END USER, 2021–2028 (USD MILLION)
    6.5 ASSAY KITS 
           6.5.1 PRODUCT APPROVALS AND LAUNCHES TO DRIVE SEGMENTAL GROWTH
                    TABLE 43 BREAST BIOPSY DEVICES MARKET FOR ASSAY KITS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 44 BREAST BIOPSY DEVICES MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 45 BREAST BIOPSY DEVICES MARKET FOR ASSAY KITS, BY TECHNIQUE, 2021–2028 (USD MILLION)
                    TABLE 46 BREAST BIOPSY DEVICES MARKET FOR ASSAY KITS, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 47 BREAST BIOPSY DEVICES MARKET FOR ASSAY KITS, BY END USER, 2021–2028 (USD MILLION)
    6.6 LIQUID BIOPSY INSTRUMENTS 
           6.6.1 ONGOING RESEARCH AND CLINICAL TRIALS TO DELIVER NOVEL SOLUTIONS IN MARKET
                    TABLE 48 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 49 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 50 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY INSTRUMENTS, BY TECHNIQUE, 2021–2028 (USD MILLION)
                    TABLE 51 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY INSTRUMENTS, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 52 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY INSTRUMENTS, BY END USER, 2021–2028 (USD MILLION)
    6.7 LOCALIZATION WIRES 
           6.7.1 WIDE USAGE OF LOCALIZATION WIRES TO LOCATE BREAST ABNORMALITIES AND LUMPS TO BOOST MARKET
                    TABLE 53 BREAST BIOPSY DEVICES MARKET FOR LOCALIZATION WIRES, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 54 BREAST BIOPSY DEVICES MARKET FOR LOCALIZATION WIRES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 55 BREAST BIOPSY DEVICES MARKET FOR LOCALIZATION WIRES, BY TECHNIQUE, 2021–2028 (USD MILLION)
                    TABLE 56 BREAST BIOPSY DEVICES MARKET FOR LOCALIZATION WIRES, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 57 BREAST BIOPSY DEVICES MARKET FOR LOCALIZATION WIRES, BY END USER, 2021–2028 (USD MILLION)
    6.8 OTHER DEVICES 
          TABLE 58 OTHER BREAST BIOPSY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 59 OTHER BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 60 OTHER BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
          TABLE 61 OTHER BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
          TABLE 62 OTHER BREAST BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
 
7 BREAST BIOPSY DEVICES MARKET, BY PROCEDURE (Page No. - 116)
    7.1 INTRODUCTION 
          TABLE 63 BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
    7.2 NEEDLE BREAST BIOPSY 
          TABLE 64 BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
           7.2.1 CORE-NEEDLE BIOPSY
                    7.2.1.1 Procedural advantages of guidance system-based biopsy to drive revenue growth
                                TABLE 65 BREAST BIOPSY DEVICES MARKET FOR CORE-NEEDLE BIOPSY, BY REGION, 2021–2028 (USD MILLION)
           7.2.2 VACUUM-ASSISTED BIOPSY
                    7.2.2.1 High diagnostic specificity and accuracy of technique to boost demand
                                TABLE 66 BREAST BIOPSY DEVICES MARKET FOR VACUUM-ASSISTED BIOPSY, BY REGION, 2021–2028 (USD MILLION)
           7.2.3 FINE-NEEDLE ASPIRATION BIOPSY
                    7.2.3.1 Drawbacks associated with procedure to limit market growth
                                TABLE 67 BREAST BIOPSY DEVICES MARKET FOR FINE-NEEDLE ASPIRATION BIOPSY, BY REGION, 2021–2028 (USD MILLION)
    7.3 OPEN SURGICAL BREAST BIOPSY 
          TABLE 68 BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
           7.3.1 EXCISIONAL BIOPSY
                    7.3.1.1 Risk of postoperative complications to hinder market growth
                                TABLE 69 BREAST BIOPSY DEVICES MARKET FOR EXCISIONAL BIOPSY, BY REGION, 2021–2028 (USD MILLION)
           7.3.2 INCISIONAL BIOPSY
                    7.3.2.1 Longer recovery period associated with incisional biopsy to restrict growth
                                TABLE 70 BREAST BIOPSY DEVICES MARKET FOR INCISIONAL BIOPSY, BY REGION, 2021–2028 (USD MILLION)
    7.4 LIQUID BREAST BIOPSY 
          TABLE 71 BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
           7.4.1 CIRCULATING TUMOR CELLS
                    7.4.1.1 Ability to provide important information on molecular properties of breast tumors to boost market
                                TABLE 72 BREAST BIOPSY DEVICES MARKET FOR CIRCULATING TUMOR CELLS, BY REGION, 2021–2028 (USD MILLION)
           7.4.2 CIRCULATING TUMOR DNA
                    7.4.2.1 Low concentrations of ctDNA to pose challenges in screening mutations
                                TABLE 73 BREAST BIOPSY DEVICES MARKET FOR CIRCULATING TUMOR DNA, BY REGION, 2021–2028 (USD MILLION)
           7.4.3 OTHER BIOMARKERS
                    TABLE 74 BREAST BIOPSY DEVICES MARKET FOR OTHER BIOMARKERS, BY REGION, 2021–2028 (USD MILLION)
 
8 BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE (Page No. - 127)
    8.1 INTRODUCTION 
          TABLE 75 BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
    8.2 IMAGE-GUIDED BIOPSY 
          TABLE 76 BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
           8.2.1 MAMMOGRAPHY-GUIDED STEREOTACTIC BIOPSY
                    8.2.1.1 Increasing number of government-initiated breast screening programs to drive segmental growth
                                TABLE 77 BREAST BIOPSY DEVICES MARKET FOR MAMMOGRAPHY-GUIDED STEREOTACTIC BIOPSY, BY REGION, 2021–2028 (USD MILLION)
           8.2.2 ULTRASOUND-GUIDED BIOPSY
                    8.2.2.1 Advantages of technique to boost adoption in coming years
                                TABLE 78 BREAST BIOPSY DEVICES MARKET FOR ULTRASOUND-GUIDED BIOPSY, BY REGION, 2021–2028 (USD MILLION)
           8.2.3 MRI-GUIDED BIOPSY
                    8.2.3.1 High cost and low specificity to affect demand
                                TABLE 79 BREAST BIOPSY DEVICES MARKET FOR MRI-GUIDED BIOPSY, BY REGION, 2021–2028 (USD MILLION)
    8.3 LIQUID BIOPSY 
          TABLE 80 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
           8.3.1 PCR-BASED BIOPSY
                    8.3.1.1 Continuous advancements in PCR technology to propel growth
                                TABLE 81 BREAST BIOPSY DEVICES MARKET FOR PCR-BASED BIOPSY, BY REGION, 2021–2028 (USD MILLION)
           8.3.2 NGS-BASED BIOPSY
                    8.3.2.1 Technological advancements and advantages to drive growth
                                TABLE 82 NGS-BASED TECHNOLOGIES FOR ONCOLOGY APPLICATIONS
                                TABLE 83 BREAST BIOPSY DEVICES MARKET FOR NGS-BASED BIOPSY, BY REGION, 2021–2028 (USD MILLION)
           8.3.3 MICROARRAY-BASED BIOPSY
                    8.3.3.1 Ongoing research and promising results to drive market growth
TABLE 84 BREAST BIOPSY DEVICES MARKET FOR MICROARRAY-BASED BIOPSY, BY REGION, 2021–2028 (USD MILLION)
    8.4 OTHER TECHNIQUES 
          TABLE 85 BREAST BIOPSY DEVICES MARKET FOR OTHER TECHNIQUES, BY REGION, 2021–2028 (USD MILLION)
 
9 BREAST BIOPSY DEVICES MARKET, BY APPLICATION (Page No. - 137)
    9.1 INTRODUCTION 
          TABLE 86 BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
    9.2 EARLY CANCER SCREENING 
           9.2.1 GROWING AWARENESS ABOUT EARLY CANCER DETECTION TO DRIVE MARKET GROWTH
                    TABLE 87 BREAST BIOPSY DEVICES MARKET FOR EARLY CANCER SCREENING, BY REGION, 2021–2028 (USD MILLION)
    9.3 THERAPY SELECTION 
           9.3.1 EMERGENCE OF PLASMA-BASED GENOTYPING TO DRIVE GROWTH IN DEVELOPED COUNTRIES
                    TABLE 88 BREAST BIOPSY DEVICES MARKET FOR THERAPY SELECTION, BY REGION, 2021–2028 (USD MILLION)
    9.4 TREATMENT MONITORING 
           9.4.1 GROWING DEMAND FOR LIQUID BIOPSY FOR REAL-TIME TREATMENT MONITORING TO BOOST MARKET
                    TABLE 89 BREAST BIOPSY DEVICES MARKET FOR TREATMENT MONITORING, BY REGION, 2021–2028 (USD MILLION)
    9.5 RECURRENCE MONITORING 
           9.5.1 UNMET CLINICAL NEEDS TO CREATE OPPORTUNITIES FOR PLAYERS
                    TABLE 90 BREAST BIOPSY DEVICES MARKET FOR RECURRENCE MONITORING, BY REGION, 2021–2028 (USD MILLION)
 
10 BREAST BIOPSY DEVICES MARKET, BY END USER (Page No. - 143)
     10.1 INTRODUCTION 
             TABLE 91 BREAST BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
     10.2 HOSPITALS & SURGICAL CENTERS 
             10.2.1 RISING DEMAND FOR QUICK AND ACCURATE DIAGNOSIS TO BOOST MARKET
                        TABLE 92 BREAST BIOPSY DEVICES MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2021–2028 (USD MILLION)
     10.3 BREAST CARE CENTERS 
             10.3.1 GROWING POPULARITY OF BREAST CARE CENTERS IN DEVELOPED COUNTRIES TO FUEL GROWTH
                        TABLE 93 BREAST BIOPSY DEVICES MARKET FOR BREAST CARE CENTERS, BY REGION, 2021–2028 (USD MILLION)
     10.4 IMAGING CLINICS & DIAGNOSTIC CENTERS 
             10.4.1 RISING NUMBER OF PRIVATE IMAGING CENTERS TO CONTRIBUTE TO MARKET GROWTH
                        TABLE 94 BREAST BIOPSY DEVICES MARKET FOR IMAGING CLINICS & DIAGNOSTIC CENTERS, BY REGION, 2021–2028 (USD MILLION)
 
11 BREAST BIOPSY DEVICES MARKET, BY REGION (Page No. - 148)
     11.1 INTRODUCTION 
             TABLE 95 BREAST BIOPSY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
     11.2 NORTH AMERICA 
             FIGURE 29 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET SNAPSHOT
             11.2.1 NORTH AMERICA: RECESSION IMPACT
                        TABLE 96 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 97 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 98 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
                        TABLE 99 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 100 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 101 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 102 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 103 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                        TABLE 104 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 105 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 106 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.2.2 US
                        11.2.2.1 US to dominate North American breast biopsy devices market during forecast period
                                      TABLE 107 US: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             11.2.3 CANADA
                        11.2.3.1 Growing incidence of breast cancer and favorable government guidelines to support market growth
                                      TABLE 108 CANADA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
     11.3 EUROPE 
             11.3.1 EUROPE: RECESSION IMPACT
                        TABLE 109 EUROPE: BREAST BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 110 EUROPE: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 111 EUROPE: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
                        TABLE 112 EUROPE: BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 113 EUROPE: BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 114 EUROPE: BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 115 EUROPE: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 116 EUROPE: BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                        TABLE 117 EUROPE: BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 118 EUROPE: BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 119 EUROPE: BREAST BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.3.2 GERMANY
                        11.3.2.1 Favorable changes in reimbursement scenario to fuel adoption of technologically advanced products
                                      TABLE 120 GERMANY: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             11.3.3 UK
                        11.3.3.1 Initiatives by public & private organizations to increase awareness about breast cancer
                                      TABLE 121 UK: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             11.3.4 FRANCE
                        11.3.4.1 Rising geriatric population to support market growth
                                      TABLE 122 FRANCE: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             11.3.5 ITALY
                        11.3.5.1 Evolving regulatory scenario for breast biopsy to boost market
                                      TABLE 123 ITALY: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             11.3.6 SPAIN
                        11.3.6.1 Government focus on early and effective breast cancer diagnosis to favor market growth
                                      TABLE 124 SPAIN: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             11.3.7 REST OF EUROPE
                        TABLE 125 REST OF EUROPE: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
     11.4 ASIA PACIFIC 
             FIGURE 30 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET SNAPSHOT
             11.4.1 ASIA PACIFIC: RECESSION IMPACT
                        TABLE 126 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 127 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 128 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
                        TABLE 129 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 130 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 131 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 132 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 133 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                        TABLE 134 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 135 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 136 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.4.2 CHINA
                        11.4.2.1 Increasing patient pool and government initiatives for healthcare development to fuel market growth
                                      TABLE 137 CHINA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             11.4.3 JAPAN
                        11.4.3.1 Presence of universal healthcare reimbursement scenario to support growth
                                      TABLE 138 JAPAN: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             11.4.4 INDIA
                        11.4.4.1 Government initiatives to improve female health to drive market growth in India
                                      TABLE 139 INDIA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             11.4.5 AUSTRALIA
                        11.4.5.1 Rising research investments and awareness campaigns to fuel growth
                                      TABLE 140 AUSTRALIA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             11.4.6 SOUTH KOREA
                        11.4.6.1 Rising R&D and promising clinical trials to positively impact market growth
                                      TABLE 141 SOUTH KOREA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             11.4.7 REST OF ASIA PACIFIC
                        TABLE 142 REST OF ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
     11.5 LATIN AMERICA 
             11.5.1 LATIN AMERICA: RECESSION IMPACT
                        TABLE 143 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 144 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 145 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
                        TABLE 146 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 147 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 148 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 149 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 150 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                        TABLE 151 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 152 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 153 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.5.2 BRAZIL
                        11.5.2.1 Brazil to dominate Latin American market during forecast period
                                      TABLE 154 BRAZIL: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             11.5.3 MEXICO
                        11.5.3.1 Availability of advanced care and increasing awareness programs to fuel market growth
                                      TABLE 155 MEXICO: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             11.5.4 REST OF LATIN AMERICA
                        TABLE 156 REST OF LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             11.5.5 MIDDLE EAST & AFRICA
                        11.5.5.1 Improving healthcare infrastructure and increasing public-private investments to drive market
             11.5.6 MIDDLE EAST & AFRICA: RECESSION IMPACT
                        TABLE 157 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 158 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
                        TABLE 159 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 160 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 161 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 162 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 163 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                        TABLE 164 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 165 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 166 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
 
12 COMPETITIVE LANDSCAPE (Page No. - 197)
     12.1 INTRODUCTION 
             FIGURE 31 KEY DEVELOPMENTS BY LEADING PLAYERS IN BREAST BIOPSY DEVICES MARKET, JANUARY 2020–FEBRUARY 2022
     12.2 STRATEGIES ADOPTED BY KEY PLAYERS 
     12.3 REVENUE SHARE ANALYSIS 
             FIGURE 32 REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS
     12.4 MARKET SHARE ANALYSIS 
             FIGURE 33 BREAST BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER (2022)
     12.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022) 
             12.5.1 STARS
             12.5.2 EMERGING LEADERS
             12.5.3 PERVASIVE PLAYERS
             12.5.4 PARTICIPANTS
                        FIGURE 34 BREAST BIOPSY DEVICES MARKET: COMPANY EVALUATION MATRIX (2022)
     12.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022) 
             12.6.1 PROGRESSIVE COMPANIES
             12.6.2 RESPONSIVE COMPANIES
             12.6.3 DYNAMIC COMPANIES
             12.6.4 STARTING BLOCKS
                        FIGURE 35 BREAST BIOPSY DEVICES MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
     12.7 COMPETITIVE BENCHMARKING 
             TABLE 167 BREAST BIOPSY DEVICES MARKET: COMPETITIVE BENCHMARKING
     12.8 COMPANY FOOTPRINT ANALYSIS 
             TABLE 168 BREAST BIOPSY DEVICES MARKET: REGIONAL FOOTPRINT ANALYSIS
     12.9 COMPETITIVE SCENARIO 
             12.9.1 PRODUCT LAUNCHES & APPROVALS
             12.9.2 DEALS
 
13 COMPANY PROFILES (Page No. - 210)
     13.1 KEY PLAYERS 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             13.1.1 HOLOGIC, INC.
                        TABLE 169 HOLOGIC, INC.: BUSINESS OVERVIEW
                        FIGURE 36 HOLOGIC, INC.: COMPANY SNAPSHOT (2022)
                        TABLE 170 HOLOGIC, INC.: PRODUCT LAUNCHES & APPROVALS
                        TABLE 171 HOLOGIC, INC.: DEALS
             13.1.2 DANAHER CORPORATION
                        TABLE 172 DANAHER CORPORATION: BUSINESS OVERVIEW
                        FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
                        TABLE 173 DANAHER CORPORATION: PRODUCT LAUNCHES
             13.1.3 BECTON, DICKINSON AND COMPANY
                        TABLE 174 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
                        FIGURE 38 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
                        TABLE 175 BECTON, DICKINSON AND COMPANY: EXPANSIONS
             13.1.4 QIAGEN
                        TABLE 176 QIAGEN: BUSINESS OVERVIEW
                        FIGURE 39 QIAGEN: COMPANY SNAPSHOT (2022)
                        TABLE 177 QIAGEN: PRODUCT LAUNCHES
             13.1.5 F. HOFFMANN-LA ROCHE LTD.
                        TABLE 178 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
                        FIGURE 40 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
             13.1.6 ARGON MEDICAL DEVICES
                        TABLE 179 ARGON MEDICAL DEVICES: BUSINESS OVERVIEW
                        TABLE 180 ARGON MEDICAL DEVICES: PRODUCT LAUNCHES
                        TABLE 181 ARGON MEDICAL DEVICES: DEALS
             13.1.7 MERIT MEDICAL SYSTEMS
                        TABLE 182 MERIT MEDICAL SYSTEMS: BUSINESS OVERVIEW
                        FIGURE 41 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2022)
                        TABLE 183 MERIT MEDICAL SYSTEMS: PRODUCT LAUNCHES & APPROVALS
                        TABLE 184 MERIT MEDICAL SYSTEMS: DEALS
             13.1.8 MENARINI SILICON BIOSYSTEMS SPA
                        TABLE 185 MENARINI SILICON BIOSYSTEMS: BUSINESS OVERVIEW
                        TABLE 186 MENARINI SILICON BIOSYSTEMS: PRODUCT LAUNCHES
                        TABLE 187 MENARINI SILICON BIOSYSTEMS: DEALS
             13.1.9 GUARDANT HEALTH, INC.
                        TABLE 188 GUARDANT HEALTH, INC.: BUSINESS OVERVIEW
                        FIGURE 42 GUARDANT HEALTH, INC.: COMPANY SNAPSHOT (2022)
                        TABLE 189 GUARDANT HEALTH, INC.: DEALS
             13.1.10 NEOGENOMICS LABORATORIES, INC.
                        TABLE 190 NEOGENOMICS LABORATORIES, INC.: BUSINESS OVERVIEW
                        FIGURE 43 NEOGENOMICS LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
                        TABLE 191 NEOGENOMICS LABORATORIES, INC.: PRODUCT LAUNCHES
                        TABLE 192 NEOGENOMICS LABORATORIES, INC.: DEALS
             13.1.11 STERYLAB S.R.L
                        TABLE 193 STERYLAB S.R.L: BUSINESS OVERVIEW
             13.1.12 BIOCEPT, INC.
                        TABLE 194 BIOCEPT, INC.: BUSINESS OVERVIEW
             13.1.13 BIO-RAD LABORATORIES, INC.
                        TABLE 195 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
                        FIGURE 44 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
             13.1.14 EXACT SCIENCES CORPORATION
                        TABLE 196 EXACT SCIENCES CORPORATION: BUSINESS OVERVIEW
                        FIGURE 45 EXACT SCIENCES CORPORATION: COMPANY SNAPSHOT (2022)
                        TABLE 197 EXACT SCIENCES CORPORATION: DEALS
             13.1.15 SYSMEX INOSTICS, INC. (A SUBSIDIARY OF SYSMEX CORPORATION)
                        TABLE 198 SYSMEX INOSTICS: BUSINESS OVERVIEW
                        FIGURE 46 SYSMEX INOSTICS: COMPANY SNAPSHOT (2022)
                        TABLE 199 SYSMEX INOSTICS: DEALS
     13.2 OTHER PLAYERS 
             13.2.1 THERMO FISHER SCIENTIFIC
             13.2.2 CARDIFF ONCOLOGY INC.
             13.2.3 MYRIAD GENETICS, INC.
             13.2.4 ILLUMINA, INC.
             13.2.5 FLUXION BIOSCIENCES, INC.
             13.2.6 FUJIFILM HOLDINGS CORPORATION
             13.2.7 INRAD, INC.
             13.2.8 IZI MEDICAL PRODUCTS
             13.2.9 REMINGTON MEDICAL INC.
             13.2.10 CP MEDICAL
 
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
14 APPENDIX (Page No. - 259)
     14.1 DISCUSSION GUIDE 
     14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     14.3 CUSTOMIZATION OPTIONS 
     14.4 RELATED REPORTS 
     14.5 AUTHOR DETAILS 

The study involved four major activities in estimating the current size of the breast biopsy devices market. Exhaustive secondary research was done to collect information on the market, peer, and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. A bottom-up approach was employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial breast biopsy devices market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the breast biopsy devices market. The primary sources from the demand side include hospitals, surgical centers, imaging centers, diagnostic centers, and breast care centers. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

Breast Biopsy Market Size, and Share

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2022, Tier 1 = >USD 10 billion, Tier 2 = USD 10 billion to USD 1 billion, Tier 3 = <USD 500 million to USD 1 billion

To know about the assumptions considered for the study, download the pdf brochure

Market Estimation Methodology

In this report, the breast biopsy devices market’s size was determined using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the market business were determined through various insights gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and key marketing executives.

Segmental revenues were calculated based on the revenue mapping of major solution/service providers to calculate the global market value. This process involved the following steps:

  • Generating a list of major global players operating in the breast biopsy devices market.
  • Mapping annual revenues generated by major global players from the product segment (or nearest reported business unit/product category)
  • Revenue mapping of major players to cover a major share of the global market share, as of 2022
  • Extrapolating the global value of the breast biopsy devices market industry

Bottom-up approach

In this report, the size of the global breast biopsy devices market was determined using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the breast biopsy devices business were determined through various insights gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and marketing executives.

Approach 1: Company revenue estimation approach

To calculate the global market value, segmental revenues were calculated based on the revenue mapping of major solution/product providers. This process involved the following steps:

  • Generating a list of major global players operating in the breast biopsy devices market
  • Mapping the annual revenues generated by major global players from the breast biopsy devices segment (or the nearest reported business unit/product category)
  • Mapping the revenues of major players to cover at least 60-70% of the global market share as of 2022
  • Extrapolating the global value of the breast biopsy devices industry

Approach 2: End user-based market estimation

During preliminary secondary research, the total sales revenue of breast biopsy devices was estimated and validated at the regional and country level, triangulated, and validated to estimate the global market value. This process involved the following steps:

  • Generating a list of major customer facilities across each Region and country
  • Identifying the average number of breast biopsy devices product supplies used by major customer facilities across each product type at the regional/country level, annually
  • Identifying the percentage contribution of major customer facilities to the overall breast biopsy devices expenditure and usage at the regional/country level, annually
  • Extrapolating the annual usage patterns for various products across major customer facilities to estimate the size of each product segment at the regional/country level, annually
  • Identifying the percentage contributions of individual market segments and subsegments to the overall breast biopsy devices market at the regional/country level

Breast Biopsy Devices Market Size Estimation: Bottom-Up Approach

Breast Biopsy Market Size, and Share

Source: MarketsandMarkets Analysis

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size from the market size estimation process explained above, the global breast biopsy devices market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the breast biopsy devices market was validated using top-down and bottom-up approaches.

Market Definition

A breast biopsy is a procedure in which a sample of breast tissue or fluid is removed to test for breast cancer. There are several types of breast biopsy procedures, such as core needle biopsy, vacuum-assisted biopsy, liquid biopsy, and open surgical breast biopsy, among others. Conventional breast biopsy procedures often utilized a free-hand technique wherein the needle was positioned at the target site while operating the imaging transducer. These advancements have improved the accuracy, efficiency, and safety of biopsy procedures, leading to increased adoption and market growth.

Key Stakeholders

  • Biopsy needles and guidance system manufacturing companies
  • Liquid biopsy assay kit manufacturers and suppliers
  • Breast care facilities and imaging centers
  • Cancer research centers
  • Hospitals and surgical centers
  • Ambulatory care centers
  • Research laboratories and academic institutes
  • Contract research organizations
  • Breast biopsy software providers
  • Medical device distributors and suppliers
  • Market research and consulting firms

Objectives of the Study

  • To define, describe, and forecast the breast biopsy market by Type, Procedure, Technique, Application, End User and Region
  • To provide detailed information regarding major factors influencing the market growth (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze micro markets with respect to their individual growth trends, prospects, and contributions to the market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast revenue of the market segments with respect to five regions: North America (US and Canada), Europe (Germany, France, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), and the Middle East & Africa.
  • To strategically profile the key players and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments in the breast biopsy market, such as product launches and product enhancements; agreements, partnerships, and collaborations; acquisitions; and R&D developments.

Available Customizations

With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for the present global breast biopsy devices market report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies

Company Information

  • Detailed analysis and profiling of additional market players (up to five)

Geographic Analysis

  • Further breakdown of the Rest of Europe's breast biopsy devices market into Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal, among others
  • Further breakdown of the Rest of Asia Pacific breast biopsy devices market into Singapore, Taiwan, New Zealand, Philippines, Malaysia, and other APAC countries
  • Further breakdown of the Rest of Latin America (RoLATAM), which comprises Argentina, Chile, Peru, Colombia, and Cuba
  • Further breakdown of the RoW market into Latin America and MEA regions
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization
Report Code
MD 3615
Published ON
Aug, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Breast Biopsy Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback